Auranofin is a gold-containing molecule, prescribed for rheumatoid arthritis and is now under study as a potential treatment for cancers due to its inhibitory effect on PKC signaling, which is required to maintain tumor-initiating phenotype (Y. Wang et al., 2013) (Butler et al., 2015). The gene discussed is PRRT2; the disease is cancer.